Kang, E.Y.-C.; Kang, C.; Wu, W.-C.; Sun, C.-C.; Chen, K.-J.; Lai, C.-C.; Chen, T.-H.; Hwang, Y.-S.
Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression. J. Clin. Med. 2021, 10, 2871.
https://doi.org/10.3390/jcm10132871
AMA Style
Kang EY-C, Kang C, Wu W-C, Sun C-C, Chen K-J, Lai C-C, Chen T-H, Hwang Y-S.
Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression. Journal of Clinical Medicine. 2021; 10(13):2871.
https://doi.org/10.3390/jcm10132871
Chicago/Turabian Style
Kang, Eugene Yu-Chuan, Chunya Kang, Wei-Chi Wu, Chi-Chin Sun, Kuan-Jen Chen, Chi-Chun Lai, Tien-Hsing Chen, and Yih-Shiou Hwang.
2021. "Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression" Journal of Clinical Medicine 10, no. 13: 2871.
https://doi.org/10.3390/jcm10132871
APA Style
Kang, E. Y.-C., Kang, C., Wu, W.-C., Sun, C.-C., Chen, K.-J., Lai, C.-C., Chen, T.-H., & Hwang, Y.-S.
(2021). Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression. Journal of Clinical Medicine, 10(13), 2871.
https://doi.org/10.3390/jcm10132871